Loading…
Krebs Biochemicals and Industries (KREBSBIO)₹59.62+3.69%Pharmaceuticals
At the end of the Jun 2026 quarter, Krebs Biochemicals and Industries' shareholders were: promoters 72.75%, FIIs 0.50%, public 26.75%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 8,518 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 72.75% | 72.75% | 72.75% | 72.75% | 72.75% | 72.75% | 72.75% | 72.75% | 72.75% | 72.75% | 72.75% | 72.75% |
| FIIs | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% | 0.50% |
| Public | 26.75% | 26.75% | 26.75% | 26.75% | 26.75% | 26.75% | 26.75% | 26.75% | 26.75% | 26.75% | 26.75% | 26.75% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 9,027 | 8,987 | 8,906 | 8,845 | 9,422 | 9,088 | 8,795 | 9,115 | 8,909 | 8,707 | 8,550 | 8,518 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Ipca Laboratories Limited | Promoter | 49.70% | 0.00 |
| Hemalatha Ravi | Promoter | 12.51% | 0.00 |
| Avinash Ravi | Promoter | 9.95% | 0.00 |
| Sun Pharmaceutical Industries Ltd | Public | 4.82% | 0.00 |
| Guttikonda Rajasekhar | Public | 1.88% | New |
| Guttikonda Vara Lakshmi | Public | 1.69% | New |
| Ajay Ravi | Promoter | 0.52% | 0.00 |
| Dr R T Ravi | Promoter | 0.11% | 0.00 |
| Aditya Ravi | Promoter | 0.05% | 0.00 |
Promoters held 72.75% of Krebs Biochemicals and Industries at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.50% (unchanged at 0.50% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
No. The Jun 2026 filing shows no pledged promoter shares.
Krebs Biochemicals and Industries had 8,518 shareholders at the end of the Jun 2026 quarter, against 9,115 a year earlier.
Sun Pharmaceutical Industries Ltd (Public) held 4.82% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.